Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children's hospitals in the United States

Clinical Infectious Diseases

Volumn 49, Issue 1, 2009, Pages 65-71

  Gerber, Jeffrey S ^a,b   Coffin, Susan E ^a   Smathers, Sarah A ^a   Zaoutis, Theoklis E ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTEREMIA; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORBIDITY; MORTALITY; OSTEOMYELITIS; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; UNITED STATES;

ADOLESCENT; BACTEREMIA; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALS; HUMANS; INCIDENCE; INFANT; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; OSTEOMYELITIS; PNEUMONIA, STAPHYLOCOCCAL; RETROSPECTIVE STUDIES; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; TREATMENT OUTCOME; UNITED STATES;

EID: 66949138112     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/599348     Document Type: Article

References (24)

1. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339: 520-32.
2. Daum RS. Clinical practice: skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. N Engl J Med 2007; 357:380-90 (erratum: N Engl J Med 2007; 357:1357).
3. Cosgrove SE, Fowler VG Jr. Management of methicillin-resistant Staph- ylococcus aureus bacteremia. Clin Infect Dis 2008; 46(Suppl 5):S386-93.
4. Deurenberg RH, Vink C, Kalenic S, Friedrich AW, Bruggeman CA, Stobberingh EE. The molecular evolution of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 2007; 13:222-35.
5. Boucher HW, Corey GR. Epidemiology of methicillin-resistant Staph- ylococcus aureus. Clin Infect Dis 2008; 46(Suppl 5):S344-9.
6. Stryjewski ME, Chambers HF. Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2008; 46(Suppl 5):S368-77.
7. Moran GJ, Krishnadasan A, Gorwitz RJ, et al.; EMERGEncy ID Net Study Group. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006; 355:666-74.
8. Kaplan SL. Implications of methicillin-resistant Staphylococcus aureus as a community-acquired pathogen in pediatric patients. Infect Dis Clin North Am 2005; 19:747-57.
9. Gorwitz RJ. A review of community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections. Pediatr Infect Dis J 2008;27:1-7.
10. McCaskill ML, Mason EO Jr, Kaplan SL, Hammerman W, Lamberth LB, Hulten KG. Increase of the USA300 clone among community- acquired methicillin- susceptible Staphylococcus aureus causing invasive infections. Pediatr Infect Dis J 2007;26:1122-7.
11. Kaplan SL, Hulten KG, Gonzalez BE, et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis 2005; 40:1785-91.
12. Ochoa TJ, Mohr J, Wanger A, Murphy JR, Heresi GP. Community- associated methicillin-resistant Staphylococcus aureus in pediatric patients. Emerg Infect Dis 2005; 11:966-8.
13. Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007; 298:1763-71.
14. Klein E, Smith DL, Laxminarayan R. Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis 2007; 13:1840-6.
15. Jarvis WR, Schlosser J, Chinn RY, Tweeten S, Jackson M. National prevalence of methicillin-resistant Staphylococcus aureus in inpatients at US health care facilities, 2006. Am J Infect Control 2007;35:631-7.
16. Kuehnert MJ, Hill HA, Kupronis BA, Tokars JI, Solomon SL, Jernigan DB. Methicillin-resistant-Staphylococcus aureus hospitalizations, United States. Emerg Infect Dis 2005; 11:868-72.
17. Feudtner C, Christakis DA, Connell FA. Pediatric deaths attributable to complex chronic conditions: a population-based study ofWashing- ton State, 1980-1997. Pediatrics 2000; 106:205-9.
18. Skiest DJ, Brown K, Cooper TW, Hoffman-Roberts H, Mussa HR, Elliott AC. Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients. J Infect 2007; 54:427-34.
19. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005; 352:1436-44.
20. Sattler CA, Mason EO Jr, Kaplan SL. Prospective comparison of risk factors and demographic and clinical characteristics of community- acquired, methicillin-resistant versus methicillin-susceptible Staphylo- coccus aureus infection in children. Pediatr Infect Dis J 2002; 21:910-7.
21. Fritz SA, Garbutt J, Elward A, Shannon W, Storch GA. Prevalence of and risk factors for community-acquired methicillin-resistant and methicillin-sensitive Staphylococcus aureus colonizationin childrenseen in a practice-based research network. Pediatrics 2008; 121:1090-8.
22. Maree CL, Daum RS, Boyle-Vavra S, Matayoshi K, Miller LG. Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections. Emerg Infect Dis 2007;13:236- 42.
23. Liu C, Graber CJ, Karr M, et al. A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staph- ylococcus aureus disease in San Francisco, 2004-2005. Clin Infect Dis 2008; 46:1637-46.
24. Popovich KJ, Weinstein RA, Hota B. Are community-associated meth- icillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? Clin Infect Dis 2008; 46:787-94.